Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 69.00p 68.00p 70.00p 69.00p 69.00p 69.00p 405 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -18.2 -0.5 - 21.84

Reneuron Share Discussion Threads

Showing 5626 to 5647 of 5650 messages
Chat Pages: 226  225  224  223  222  221  220  219  218  217  216  215  Older
DateSubjectAuthorDiscuss
17/5/2018
12:16
Rotors..took it off the LSE board director buys and sells.When a director exercises options ,it shows they were sold following exercising.I think.cheers
ashtree2
17/5/2018
11:12
Here's hoping its not good money after bad... They do seem to have some great assets here, but maybe their PR should be working better. D
dennisbergkamp
16/5/2018
10:13
17th feb2016..Hunt exercised options of 5,361,673 shares at 1p and sold the bulk of them for around 3p so did very well thank you.He is holding just over 2million from Jan this year..So today one can buy at 0.6p rather surprised that directors arnt piling in.Please correct me if I am wrong.
ashtree2
16/5/2018
10:01
ashtree2, not sure the figures prove that theory. CFO had a flurry of options exercised, some sold, in Feb 2016 - but a net purchase. And then a further buy in Feb 2017. Where did you get your data? Regards.
rotors
16/5/2018
09:21
share price has been decimated by director selling otherwise can see no reason for this low price.only just recently seen this one and have taken a nibble.
ashtree2
15/5/2018
08:22
Irrelevant. I'm now down to the last guinea pig in the petting zoo.
small crow
14/5/2018
21:59
Was that your last Goat or last Groat? slight difference in value there S.C. hTTps://en.wikipedia.org/wiki/Groat_(coin)
algernon2
14/5/2018
09:12
I lost my farm on the stock market years ago. I'm now betting my last goat.
small crow
14/5/2018
08:56
Just don't bet the farm.
masingi
14/5/2018
08:55
New Tech /Small Crow Yes indeed, the fundamentals are sound and the science has potential. Time to hold your nerve and sort the men from the boys.
masingi
04/5/2018
10:24
Yes, and not the only biotech/pharma in the field - some much bigger cos are investing in exosomes so it will be a race. I suspect RENE will at least be among the front runner, more than that its impossible to judge. So, yes, I would say definitely worth a punt - best case scenario, pennies turn into pounds!
small crow
04/5/2018
08:13
RENE - Exosome treatment: 19 minutes 30 sec in there is a slide showing the Exosome treatment tested preclinical in cancer tumours. https://www.youtube.com/watch?v=zSG7Rnuo3aE The graph shows the average results of 5 in vitro studies. After 18 - 21 days the tumours completely collapsed. The photos show the same repeated in vivo (with animals) again resulting in tumour collapse. It basically programs the cancer cells "to die". - 12 minutes onwards MH says the new Exosome treatment causes cancer tumour "collapse" after 18 days, leaving just "cellular debris". It seems to be "programming cancer cells to adopt a normal cycle of cell death." https://www.youtube.com/watch?v=7w55ERUMpIM This could be a major breakthrough. Clinical trial about to start next year in potential breakthrough treatment and shares at an all time low, makes Rene an obvious BUY opportunity.
new tech
03/5/2018
08:04
nsk1 2007, 0.40p Today, 0.0063p
ps0u3165
02/5/2018
18:46
What's it now, if you consider consolidation for LTH's...£0.065
nsk1
02/5/2018
09:00
Yes the science looks Good, but to be honest who would ever know if it was all smoke and mirrors. We all want to be in the next Yahoo, that's why we're here. It's a punt pure and simple.Tin hat's on and hope for the best........tallyho!!
bigspuds
01/5/2018
22:20
In my experience it's either a hidden clinical disaster, or a fund wants out regardless of price. The first is a good potential short, the second an equally good potential long. But which is it? Or of course something else entirely...
supernumerary
01/5/2018
21:52
Only just caught up with today's market moves. Can't believe this has tanked so badly. Post consolidation drop was to be expected but this now appears to be written off in terms of clinical potential. I've taken some big hits on life science start-ups and this looks to be another
audigger
01/5/2018
20:14
Is somebody dumping these? science looks OK. They only list 4 major shareholders - Woodford, Wales Life Sciences, Invesco and Aviva - has somebody decided to go awol? Biggish volume today, TR-1 to come maybe? I knew that 100:1 would be painful for holders...
supernumerary
01/5/2018
19:36
Evening algernon. Been better.
volsung
01/5/2018
18:31
Evening Volsung, Bigspuds, not too good at the moment is it?
algernon2
01/5/2018
15:18
Mind you I have bought most of it at some point
volsung
17/4/2018
08:47
Not that we're any better fixed lol
bigspuds
Chat Pages: 226  225  224  223  222  221  220  219  218  217  216  215  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180522 12:10:05